398 related articles for article (PubMed ID: 25332897)
1. Renin-angiotensin system in the kidney: What is new?
Ferrão FM; Lara LS; Lowe J
World J Nephrol; 2014 Aug; 3(3):64-76. PubMed ID: 25332897
[TBL] [Abstract][Full Text] [Related]
2. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
3. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
4. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system revisited.
Fyhrquist F; Saijonmaa O
J Intern Med; 2008 Sep; 264(3):224-36. PubMed ID: 18793332
[TBL] [Abstract][Full Text] [Related]
6. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
7. New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.
Zhuo JL; Ferrao FM; Zheng Y; Li XC
Front Endocrinol (Lausanne); 2013; 4():166. PubMed ID: 24273531
[TBL] [Abstract][Full Text] [Related]
8. Role of non-classical renin-angiotensin system axis in renal fibrosis.
Lv LL; Liu BC
Front Physiol; 2015; 6():117. PubMed ID: 25954204
[TBL] [Abstract][Full Text] [Related]
9. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
10. Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.
Slamkova M; Zorad S; Krskova K
Endocr Regul; 2016 Oct; 50(4):229-240. PubMed ID: 27941178
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
12. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.
Muñoz MC; Burghi V; Miquet JG; Giani JF; Banegas RD; Toblli JE; Fang Y; Wang F; Bartke A; Dominici FP
J Endocrinol; 2014 May; 221(2):215-27. PubMed ID: 24756097
[TBL] [Abstract][Full Text] [Related]
14. Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.
Costa-Besada MA; Valenzuela R; Garrido-Gil P; Villar-Cheda B; Parga JA; Lanciego JL; Labandeira-Garcia JL
Mol Neurobiol; 2018 Jul; 55(7):5847-5867. PubMed ID: 29086247
[TBL] [Abstract][Full Text] [Related]
15. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
16. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
17. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
18. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
19. Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension.
Moon JY
Electrolyte Blood Press; 2013 Dec; 11(2):41-5. PubMed ID: 24627703
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
